Share Facebook Twitter LinkedIn Pinterest Email Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha approval FDA multiple Ocrevus Roche sclerosis therapy wins yearly Zunovo